MUDDY/insights

← Case indexN21

Noble Group (SGX: N21)

Iceberg Research's February 2015 short, multi-year mark-to-model contestation, and the 2018 break-up of one of Asia's largest commodity traders.

Noble Group Holdings corporate logo
Noble Group — SGX-listed commodity-trading conglomerateLogo via Wikimedia Commons
Key FactDetail
ReportForensic Short — Closed Case
Publication dateJanuary 15, 2019
IssuerNoble Group Limited (formerly one of Asia's largest commodity-trading houses)
TickerSGX: N21 (delisted)
Original shortIceberg Research — published in serial form starting February 2015
Headline post-publication eventsShare price declines from ~S$1.20 (early 2015) to under S$0.10 (2017); multi-year auditor changes and writedowns; SGX disciplinary action; 2018 creditor-led restructuring; delisting and break-up
RatingSHORT — Closed Case

Why We Are Publishing Today

Noble Group is the modern reference case for mark-to-model commodity-trading accounting concerns at a globally-significant listed trading house. Iceberg Research's serial February 2015 onward publications alleged that Noble's "marketing-agreement" and other long-dated commodity contracts were carried on the balance sheet at fair-value marks that materially exceeded their realistic cash-realization value. The three years between the Iceberg publication and the 2018 creditor-led restructuring constitute one of the most-studied commodity-trading-house restructurings in Asian capital markets.


Section 1 — The Iceberg Thesis (February 2015 onward)

Iceberg Research's published commentary alleged that Noble Group:

  • Carried long-dated "marketing-agreement" contracts — particularly in the coal and other energy-commodity verticals — at fair-value marks that, in Iceberg's reading, materially exceeded the realistic cash realization of those contracts;
  • Reported earnings that depended substantially on unrealized fair-value gains rather than realized commodity-trading cash margin;
  • Used auditor-engagement arrangements that limited the ability of external parties to independently verify the marks.

Iceberg published the thesis in serial form across multiple installments. The early publications did not include a formal disclosure of position; subsequent publications and other short-side participants made their positioning more explicit.

Section 2 — Share-Price Collapse and Auditor Responses (2015–2017)

The post-publication market reaction unfolded across multiple years:

  • 2015. Share price falls from approximately S$1.20 (early 2015) into the S$0.50–0.70 range; PricewaterhouseCoopers engaged as a special-review auditor; Noble defended its accounting practices.
  • 2016. Continued share-price decline; Noble entered into a series of asset disposals (including the Noble Americas Energy Solutions sale to Calpine in October 2016 for approximately US$1.05B).
  • 2017. Substantial write-downs to the long-dated commodity-contract book are recognized; the residual listed equity continues to decline below S$0.50; auditor sign-off increasingly qualified in tone.
  • Mid-2017 onward. Singapore Exchange (SGX) regulatory action and Monetary Authority of Singapore (MAS) / Accounting and Corporate Regulatory Authority (ACRA) inquiry develop in parallel.

Section 3 — The 2018 Restructuring and Break-Up

In 2018, Noble Group entered into a creditor-led restructuring under which:

  • Senior creditors received approximately 70% of the equity of a successor entity ("New Noble") in exchange for a substantial portion of the debt;
  • Common shareholders received approximately 10% of the successor entity (with residual percentages allocated to management and other parties);
  • The historical Noble Group listed entity was delisted from the SGX following completion of the restructuring;
  • New Noble was reconstituted as a smaller, more-focused commodity-trading entity.

The restructuring is, in absolute terms, among the largest commodity-trading-house restructurings of the post-2010 cycle.

Section 4 — Regulator and Audit-Watchdog Outcomes

Through the 2018–2020 period, Singapore authorities pursued ancillary proceedings:

  • SGX disciplinary action against certain former Noble Group officers and against the entity in respect of disclosure practices;
  • MAS and ACRA inquiry into accounting and audit-quality matters.

The Singapore enforcement track produced administrative outcomes but did not, to our knowledge, produce criminal prosecutions of named former officers.

Section 5 — Where Things Stand (January 2019) and What Muddy Insights Takes From The Case

As of January 2019:

  • Noble Group's historical listed entity is wound down via the 2018 restructuring; common equity is largely extinguished.
  • New Noble continues to operate as a smaller commodity-trading entity outside the SGX listing.
  • The Singapore regulator track is substantively closed.

What Muddy Insights takes from the Noble Group case:

  1. Mark-to-model commodity-trading concerns generalize. The Iceberg template — focusing on long-dated contract fair-value marks that depend on management assumptions about future commodity prices and counterparty performance — has subsequently been applied to other listed trading houses.
  2. Multi-year contestation is the norm in mark-to-model cases. As with Burford in litigation finance, mark-to-model commodity-trading cases tend to resolve across years rather than months, as the question of whether the marks were "correct" only definitively resolves through subsequent realization or impairment.
  3. Creditor-led restructurings are the modal mechanism by which large trading houses recapitalize. The 70/10 creditor/shareholder split in New Noble's emergence is broadly consistent with subsequent restructurings of stressed commodity-trading and similar fair-value-dependent businesses.

Source Index (selected)

  • Iceberg Research — published commentary on Noble Group, serial publications from February 2015.
  • Noble Group Limited — Annual Reports 2014 through 2017; Form 6-K equivalent SGX disclosures.
  • Noble Group — 2018 creditor-led restructuring documentation, SGX filings.
  • Singapore Exchange (SGX) RegCo — disciplinary action notices relating to Noble Group disclosure practices.
  • Monetary Authority of Singapore (MAS) and Accounting and Corporate Regulatory Authority (ACRA) — public statements relating to Noble Group inquiries.

— Muddy Insights, January 15, 2019.

// More files

  1. 028CURR · 2026-10-21Currenc Group Inc. (NASDAQ: CURR) — Forensic FileA Charging Order Over The Only Asset That Matters. The Same 100,465 Tranglo Shares Sold For US$400M Are Now Charged To A Judgment Creditor.NOT RATED — Forensic File
  2. 027DLXY · 2026-07-21Delixy Holdings Ltd. (NASDAQ: DLXY) — Forensic Short ReportThe IPO Funded An Exit, Not An Expansion. Dividends Out 4x What The Public Put In.NOT RATED — Research case study
  3. 026TROO · 2026-07-15TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateThe August 20 Endgame: Winding-Up Exposure, Suspension Mechanics, And A Support Bid Running On FumesSHORT — High conviction
  4. 025ADANIENT · 2026-05-15Adani Enterprises (NSE: ADANIENT)Three years after Hindenburg, two years after OCCRP, eighteen months after the EDNY indictment — what the public record now shows.SHORT — Update
  5. 024TROO · 2026-05-05TROOPS, Inc. (NASDAQ: TROO) — Forensic Short UpdateAuditor Replaced. Lock-Up Eased. Annual Report Past Due.SHORT — High conviction
  6. 023TRE · 2026-04-15Sino-Forest Corporation (TSX: TRE)The founding case of the modern China-short genre — fifteen years on.SHORT — Closed Case
  7. 022BUR · 2026-03-30Burford Capital (NYSE/LSE: BUR)Six years on from Muddy Waters' mismarking thesis — what the Second Circuit's March 2026 reversal of the YPF judgment changes.NEUTRAL
  8. 021IEP · 2026-02-25Icahn Enterprises L.P. (NASDAQ: IEP)Three years after Hindenburg's "Pied Piper of Pumpland" — distributions, the SEC settlement, and the margin-loan unwind.SHORT — Update
  9. 020WDI · 2026-02-01Wirecard AG (XETRA: WDI) — Closed-Case RetrospectiveSix years after the €1.9B missing cash — what a streamlined trial, a €140M civil award, and the Marsalek-as-FSB-asset disclosures now confirm.SHORT — Closed Case
  10. 019NKLA · 2026-01-15Nikola Corporation (NASDAQ: NKLA)The Hindenburg short, the Milton conviction, the Trump pardon, and the company's own Chapter 11.SHORT — Closed Case
  11. 018MAGH · 2025-12-02Magnitude International Ltd. (NASDAQ: MAGH) — Forensic ShortPenny-Priced Pre-IPO Equity, Eight-Month Cashout, Resale Shelf Engineered for Insider Exit.SHORT — High conviction
  12. 017VRX · 2025-10-21Valeant Pharmaceuticals (NYSE: VRX, now Bausch Health: BHC)Citron's "Pharmaceutical Enron" call, the Philidor disclosure, and the ten-year recovery that never came.SHORT — Closed Case
  13. 016TIO · 2025-09-01Tingo Group (NASDAQ: TIO)Hindenburg's June 2023 short, SEC fraud charges, the $250M civil judgment, and the founder still at large.SHORT — Closed Case
  14. 015EBIX · 2024-09-15Ebix, Inc. (NASDAQ: EBIX)Hindenburg's June 2021 short, the December 2023 Chapter 11, the $400M Zinnia sale, and the August 2024 emergence under Eraaya LifeSpaces sponsorship.SHORT — Update
  15. 014FFGRP · 2024-07-15Folli Follie (ATHEX: FFGRP)QCM's May 2018 short, the largest stock-market fraud in modern Greek history, and the June 2024 prison sentences.SHORT — Closed Case
  16. 013SNH · 2024-04-15Steinhoff International (JSE: SNH)Viceroy's December 2017 short, €7B+ of confirmed accounting irregularities, and the July 2023 vote to dissolve.SHORT — Closed Case
  17. 012RIDE · 2024-04-01Lordstown Motors (NASDAQ: RIDE, now Nu Ride: NRDE)From SPAC pre-orders to Chapter 11 to a litigation-vehicle reorganization.SHORT — Closed Case
  18. 011GSX · 2022-09-15GSX Techedu (NYSE: GSX, now Gaotu: GOTU)Muddy Waters' May 2020 short, the July 2021 "double reduction" policy that vindicated the broader sector thesis, and the 2022 HFCAA delisting.SHORT — Closed Case
  19. 010EROS · 2022-05-15Eros International / Eros STX Global (NYSE: EROS, formerly)Kerrisdale's November 2015 short, the 2020 merger with STX Entertainment, and the 2022 separation that effectively ended the listed parent.SHORT — Closed Case
  20. 009QPP · 2021-09-15Quindell PLC (LSE AIM: QPP, now Watchstone)Gotham City Research's April 2014 short, the £637M Slater & Gordon sale, the £11M settlement that followed, and the SFO investigation that ended without charge.SHORT — Closed Case
  21. 008SONG · 2020-10-15Akazoo S.A. (NASDAQ: SONG)QCM's April 2020 short, SEC fraud charges, and the fastest US-regulator resolution of a SPAC-era fraud.SHORT — Closed Case
  22. 007INSY · 2020-02-15Insys Therapeutics (NASDAQ: INSY)Citron's August 2016 short, the Subsys opioid-marketing prosecution, the June 2019 bankruptcy, and the first US pharmaceutical-executive RICO conviction for opioid marketing.SHORT — Closed Case
  23. 006ON · 2020-01-15Bio-on S.p.A. (Borsa Italiana AIM: ON) — Forensic Short Closed CaseAuditor-quality bioplastics revenue, a same-quarter founder arrest, and the fastest closure of any modern European forensic-short case.SHORT — Closed Case
  24. 005NQ · 2018-01-15NQ Mobile (NYSE: NQ)Muddy Waters' October 2013 short, four years of contested public posture, and the eventual NYSE delisting in 2017.SHORT — Closed Case
  25. 004FMCN · 2015-09-15Focus Media (NASDAQ: FMCN, formerly)Muddy Waters' November 2011 short, the 2013 take-private at a premium, and the 2015 China A-share relisting at a multiple of the take-private price.SHORT — Counter-Case
  26. 003GOW · 2014-08-01Let's Gowex (BME MAB: GOW)Gotham City Research's July 2014 short, the CEO confession within days, and the fastest forensic-short to bankruptcy in the modern catalogue.SHORT — Closed Case
  27. 002CCME · 2013-12-15China MediaExpress Holdings (NASDAQ: CCME)Muddy Waters' February 2011 short, auditor Deloitte's resignation, and the SEC fraud charges that followed.SHORT — Closed Case
  28. 001LFT · 2013-12-15Longtop Financial Technologies (NYSE: LFT)Citron's April 2011 short, Deloitte's May 2011 resignation letter, and the SEC's signature fraud case of the 2011 China-short wave.SHORT — Closed Case